A Phase I/II Trial in Patients with Metastatic GastrointestinalEpithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the GeneEncoding CISH was Inactivated Using the CRISPR/Cas9 System (CPRC # 2019LS002)

Project: Research project

Project Details

Description

A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/Cas9 System (CPRC # 2019LS002)
StatusFinished
Effective start/end date3/20/19 → 3/31/24

Funding

  • INTIMA BIOSCIENCES, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint